Cargando…

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi

BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabai, Julia, Namakhoma, Ireen, Tweya, Hannock, Phiri, Sam, Schnitzler, Paul, Neuhann, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185090/
https://www.ncbi.nlm.nih.gov/pubmed/25280736
http://dx.doi.org/10.3402/gha.v7.24795
_version_ 1782337944543035392
author Tabatabai, Julia
Namakhoma, Ireen
Tweya, Hannock
Phiri, Sam
Schnitzler, Paul
Neuhann, Florian
author_facet Tabatabai, Julia
Namakhoma, Ireen
Tweya, Hannock
Phiri, Sam
Schnitzler, Paul
Neuhann, Florian
author_sort Tabatabai, Julia
collection PubMed
description BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the prevention of temporary/permanent loss of patients in care. Understanding reasons for treatment interruption (TI) can inform strategies for improving drug adherence and retention in care. OBJECTIVE: To evaluate key characteristics of patients resuming ART after TI at the Lighthouse Clinic in Lilongwe, Malawi, and to identify their reasons for interrupting ART. DESIGN: This study uses a mixed methods design to evaluate patients resuming ART after TI. We analysed an assessment form for patients with TI using pre-defined categories and a comments field to identify frequently stated reasons for TI. Additionally, we conducted 26 in-depth interviews to deepen our understanding of common reasons for TI. In-depth interviews also included the patients’ knowledge about ART and presence of social support systems. Qualitative data analysis was based on a thematic framework approach. RESULTS: A total of 347 patients (58.2% female, average age 35.1±11.3 years) with TI were identified. Despite the presence of social support and sufficient knowledge of possible consequences of TI, all patients experienced situations that resulted in TI. Analysis of in-depth interviews led to new and distinct categories for TI. The most common reason for TI was travel (54.5%, n=80/147), which further differentiated into work- or family-related travel. Patients also stated transport costs and health-care-provider-related reasons, which included perceived/enacted discrimination by health care workers. Other drivers of TI were treatment fatigue/forgetfulness, the patients’ health status, adverse drug effects, pregnancy/delivery, religious belief or perceived/enacted stigma. CONCLUSIONS: To adequately address patients’ needs on a lifelong therapy, adherence-counselling sessions require provision of problem-solving strategies for common barriers to continuous care.
format Online
Article
Text
id pubmed-4185090
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-41850902014-10-14 Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi Tabatabai, Julia Namakhoma, Ireen Tweya, Hannock Phiri, Sam Schnitzler, Paul Neuhann, Florian Glob Health Action Original Article BACKGROUND: In recent years, scaling up of antiretroviral therapy (ART) in resource-limited settings moved impressively towards universal access. Along with these achievements, public health HIV programs are facing a number of challenges including the support of patients on lifelong therapy and the prevention of temporary/permanent loss of patients in care. Understanding reasons for treatment interruption (TI) can inform strategies for improving drug adherence and retention in care. OBJECTIVE: To evaluate key characteristics of patients resuming ART after TI at the Lighthouse Clinic in Lilongwe, Malawi, and to identify their reasons for interrupting ART. DESIGN: This study uses a mixed methods design to evaluate patients resuming ART after TI. We analysed an assessment form for patients with TI using pre-defined categories and a comments field to identify frequently stated reasons for TI. Additionally, we conducted 26 in-depth interviews to deepen our understanding of common reasons for TI. In-depth interviews also included the patients’ knowledge about ART and presence of social support systems. Qualitative data analysis was based on a thematic framework approach. RESULTS: A total of 347 patients (58.2% female, average age 35.1±11.3 years) with TI were identified. Despite the presence of social support and sufficient knowledge of possible consequences of TI, all patients experienced situations that resulted in TI. Analysis of in-depth interviews led to new and distinct categories for TI. The most common reason for TI was travel (54.5%, n=80/147), which further differentiated into work- or family-related travel. Patients also stated transport costs and health-care-provider-related reasons, which included perceived/enacted discrimination by health care workers. Other drivers of TI were treatment fatigue/forgetfulness, the patients’ health status, adverse drug effects, pregnancy/delivery, religious belief or perceived/enacted stigma. CONCLUSIONS: To adequately address patients’ needs on a lifelong therapy, adherence-counselling sessions require provision of problem-solving strategies for common barriers to continuous care. Co-Action Publishing 2014-09-30 /pmc/articles/PMC4185090/ /pubmed/25280736 http://dx.doi.org/10.3402/gha.v7.24795 Text en © 2014 Julia Tabatabai et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tabatabai, Julia
Namakhoma, Ireen
Tweya, Hannock
Phiri, Sam
Schnitzler, Paul
Neuhann, Florian
Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title_full Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title_fullStr Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title_full_unstemmed Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title_short Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi
title_sort understanding reasons for treatment interruption amongst patients on antiretroviral therapy – a qualitative study at the lighthouse clinic, lilongwe, malawi
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185090/
https://www.ncbi.nlm.nih.gov/pubmed/25280736
http://dx.doi.org/10.3402/gha.v7.24795
work_keys_str_mv AT tabatabaijulia understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi
AT namakhomaireen understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi
AT tweyahannock understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi
AT phirisam understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi
AT schnitzlerpaul understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi
AT neuhannflorian understandingreasonsfortreatmentinterruptionamongstpatientsonantiretroviraltherapyaqualitativestudyatthelighthousecliniclilongwemalawi